Capital Fund Management (CFM)’s CVS Health CVS Stock Holding History

Capital Fund Management (CFM)’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.05M	Sell	28,600 -438,300	-94%	-$33.8M	0.01%	1339
2025 Q4	$37.1M	Buy	466,900 +19,400	+4%	+$1.53M	0.1%	274
2025 Q3	$33.7M	Sell	447,500 -527,000	-54%	-$36.1M	0.09%	307
2025 Q2	$67.2M	Sell	974,500 -698,900	-42%	-$45.8M	0.19%	136
2025 Q1	$113M	Buy	1,673,400 +202,300	+14%	+$12.1M	0.33%	48
2024 Q4	$66M	Buy	1,471,100 +241,200	+20%	+$13.5M	0.17%	168
2024 Q3	$77.3M	Sell	1,229,900 -13,600	-1%	-$793K	0.21%	117
2024 Q2	$73.4M	Buy	1,243,500 +868,900	+232%	+$54.4M	0.22%	119
2024 Q1	$29.9M	Sell	374,600 -529,000	-59%	-$40.4M	0.09%	303
2023 Q4	$71.3M	Buy	903,600 +170,300	+23%	+$12.1M	0.19%	119
2023 Q3	$51.2M	Sell	733,300 -514,500	-41%	-$36.5M	0.18%	149
2023 Q2	$86.3M	Buy	1,247,800 +785,600	+170%	+$55.9M	0.35%	51
2023 Q1	$34.3M	Buy	462,200 +370,600	+405%	+$31.1M	0.16%	152
2022 Q4	$8.54M	Buy	91,600 +22,800	+33%	+$2.2M	0.06%	457
2022 Q3	$6.56M	Sell	68,800 -135,300	-66%	-$13.4M	0.05%	461
2022 Q2	$18.9M	Sell	204,100 -241,900	-54%	-$23.6M	0.17%	149
2022 Q1	$45.1M	Buy	446,000 +150,400	+51%	+$15.8M	0.37%	37
2021 Q4	$30.5M	Sell	295,600 -35,500	-11%	-$3.28M	0.22%	106
2021 Q3	$28.1M	Buy	331,100 +181,200	+121%	+$15.2M	0.21%	119
2021 Q2	$12.5M	Buy	149,900 +129,100	+621%	+$10.6M	0.1%	267
2021 Q1	$1.56M	Sell	20,800 -87,500	-81%	-$6.37M	0.02%	832
2020 Q4	$7.4M	Sell	108,300 -120,400	-53%	-$7.83M	0.07%	333
2020 Q3	$13.4M	Sell	228,700 -15,000	-6%	-$933K	0.16%	157
2020 Q2	$15.8M	Sell	243,700 -643,400	-73%	-$40.5M	0.25%	114
2020 Q1	$52.6M	Buy	887,100 +69,300	+8%	+$4.63M	0.81%	11
2019 Q4	$60.8M	Buy	817,800 +104,000	+15%	+$7.3M	0.48%	31
2019 Q3	$45M	Sell	713,800 -218,500	-23%	-$12.9M	0.41%	45
2019 Q2	$50.8M	Buy	932,300 +293,700	+46%	+$15.8M	0.46%	28
2019 Q1	$34.4M	Buy	638,600 +455,100	+248%	+$28.1M	0.31%	68
2018 Q4	$12M	Sell	183,500 -160,700	-47%	-$12M	0.11%	261
2018 Q3	$27.1M	Sell	344,200 -509,900	-60%	-$36.5M	0.15%	173
2018 Q2	$55M	Buy	854,100 +849,400	+18,072%	+$56M	0.29%	81
2018 Q1	$292K	Sell	4,700 -11,000	-70%	-$789K	﹤0.01%	1643
2017 Q4	$1.14M	Sell	15,700 -4,700	-23%	-$342K	0.01%	1171
2017 Q3	$1.66M	Sell	20,400 -5,700	-22%	-$451K	0.01%	816
2017 Q2	$2.1M	Sell	26,100 -795,200	-97%	-$62.8M	0.02%	700
2017 Q1	$64.5M	Buy	821,300 +367,900	+81%	+$29.4M	0.54%	26
2016 Q4	$35.8M	Buy	453,400 +345,000	+318%	+$27.9M	0.31%	83
2016 Q3	$9.65M	Buy	108,400 +105,800	+4,069%	+$9.99M	0.09%	277
2016 Q2	$249K	Sell	2,600 -1,200	-32%	-$120K	﹤0.01%	1379
2016 Q1	$394K	Sell	3,800 -258,000	-99%	-$25.1M	﹤0.01%	1236
2015 Q4	$25.6M	Sell	261,800 -204,200	-44%	-$20M	0.26%	89
2015 Q3	$45M	Buy	466,000 +153,500	+49%	+$16.1M	0.5%	28
2015 Q2	$32.8M	Buy	312,500 +161,300	+107%	+$16.5M	0.42%	43
2015 Q1	$15.6M	Buy	151,200 +24,300	+19%	+$2.46M	0.21%	132
2014 Q4	$12.2M	Buy	126,900 +41,200	+48%	+$3.63M	0.14%	188
2014 Q3	$6.82M	Buy	85,700 +50,500	+143%	+$3.98M	0.08%	327
2014 Q2	$2.65M	Sell	35,200 -19,000	-35%	-$1.44M	0.03%	634
2014 Q1	$4.06M	Buy	54,200 +16,000	+42%	+$1.13M	0.05%	442
2013 Q4	$2.73M	Buy	+38,200	New	+$2.45M	0.03%	577

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Fund Management (CFM)'s CVS Position: Q3 2023 in Review

Capital Fund Management (CFM) sold out of CVS Health (CVS) in Q3 2023, closing a stake of 255,285 shares — an estimated $18.1M sold.

Capital Fund Management (CFM) first reported a position in CVS in Q4 2013 and held it in 17 quarters. The position peaked at $51.7M in Q1 2023. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

Capital Fund Management (CFM) reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
Capital Fund Management (CFM) sold 255,285 CVS Health shares in Q3 2023, an estimated $18.1M.
Capital Fund Management (CFM) first reported a position in CVS Health in Q4 2013 and held it in 17 quarters.
Capital Fund Management (CFM)'s CVS Health position peaked at $51.7M in Q1 2023.
2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2023, filed 14 Nov 2023.